Flores-Rábago Karla M, Rivera-Mendoza Daniel, Vilchis-Nestor Alfredo R, Juarez-Moreno Karla, Castro-Longoria Ernestina
Department of Microbiology, Center for Scientific Research and Higher Education of Ensenada (CICESE), Ensenada 22860, Mexico.
Sustainable Chemistry Research Joint Center UAEM-UNAM (CCIQS), Toluca 50200, Mexico.
Antibiotics (Basel). 2023 Jul 29;12(8):1251. doi: 10.3390/antibiotics12081251.
Copper oxide nanoparticles (CuONPs) were synthesized using an eco-friendly method and their antimicrobial and biocompatibility properties were determined. The supernatant and extract of the fungus yielded small, quasi-spherical NPs with an average size of 4.5 ± 1.9 nm and 5.2 ± 2.1 nm, respectively. Nanoparticles were characterized by UV-Vis spectroscopy, transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), dynamic light scattering (DLS), and zeta potential analysis. CuONPs showed antimicrobial activity against (), (), and (). The half-maximal inhibitory concentration (IC50) for was 8.5 µg/mL, for was 4.1 µg/mL, and for was 10.2 µg/mL. The ultrastructural analysis of bacteria exposed to CuONPs revealed the presence of small CuONPs all through the bacterial cells. Finally, the toxicity of CuONPs was analyzed in three mammalian cell lines: hepatocytes (AML-12), macrophages (RAW 264.7), and kidney (MDCK). Low concentrations (<15 µg/mL) of CuONPs-E were non-toxic to kidney cells and macrophages, and the hepatocytes were the most susceptible to CuONPs-S. The results obtained suggest that the CuONPs synthesized using the extract of the fungus could be further evaluated for the treatment of superficial infectious diseases.
采用一种环保方法合成了氧化铜纳米颗粒(CuONPs),并测定了其抗菌性能和生物相容性。该真菌的上清液和提取物分别产生了平均尺寸为4.5±1.9纳米和5.2±2.1纳米的小的准球形纳米颗粒。通过紫外可见光谱、透射电子显微镜(TEM)、傅里叶变换红外光谱(FTIR)、X射线衍射(XRD)、动态光散射(DLS)和zeta电位分析对纳米颗粒进行了表征。CuONPs对()、()和()表现出抗菌活性。对()的半数最大抑制浓度(IC50)为8.5微克/毫升,对()为4.1微克/毫升,对()为10.2微克/毫升。对暴露于CuONPs的细菌进行的超微结构分析显示,在整个细菌细胞中都存在小的CuONPs。最后,在三种哺乳动物细胞系中分析了CuONPs的毒性:肝细胞(AML-12)、巨噬细胞(RAW 264.7)和肾细胞(MDCK)。低浓度(<15微克/毫升)的CuONPs-E对肾细胞和巨噬细胞无毒,而肝细胞对CuONPs-S最敏感。所得结果表明,使用该真菌提取物合成的CuONPs可进一步评估用于治疗浅表感染性疾病。